At RSNA 2012, GE Healthcare announced a first-of-its-kind agreement with the University of Wisconsin (UW) School of Medicine and Public Health for the purpose of providing physicians with more tools to optimize radiation dose, take clinically-useful images, and potentially reduce the frequency of repeat computed tomography (CT) scans.

As part of a process to completely integrate the patient's electronic medical record (EMR) with treatment planning activities, Elekta has introduced MOSAIQ Evaluate, a toolset that unites plan and dose review capabilities in a single software framework, MOSAIQ Oncology Information System (OIS). Uniting MOSAIQ and powerful treatment planning review capabilities streamlines planning activities inside the patient chart, reducing patient wait times and delays and improving efficiency and productivity in the department. Elekta recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for MOSAIQ Evaluate.

Fovia Medical Inc. and Blackford Analysis Ltd. announced plans to deliver compatible SDKs to the medical advanced visualization market.

Medweb announced the availability of the Medweb Zero Footprint Viewer, enabling clinicians to access and view patient images across myriad of desktops and mobile devices in response to the increasing demand of BYOD (bring your own devices) architectures. Included with the Medweb zero footprint viewer are all the basic functions clinicians need for viewing medical images and reports from a multitude of clinical imaging devices from the imaging department, as well as a suite of handheld diagnostic tools.

CIVCO Medical Solutions now offers sterile interventional patient drapes, providing another layer of infection control. The latex-free patient drapes allow complete access to the area of interest while protecting both patient and clinician from infectious bodily fluids. Available in multiple sizes and design variations, these patient drapes are ideal for PICC lines, ports, CT biopsies, ultrasound biopsies, needle localizations, cyst aspirations and other interventional procedures.


Breast cancer is the second leading cause of cancer deaths among women in the United States (2005-2009). Breast cancer deaths are going down the fastest among white women compared to women of other races and ethnicities. Black women have the highest death rates of all racial and ethnic groups and are 40% more likely to die of breast cancer than white women. The reasons for this difference result from many factors including having more aggressive cancers and fewer social and economic resources. To improve this disparity, black women need more timely follow-up and improved access to high-quality treatment.
Breast Cancer Ribbon_iStock

New research published in the January issue of The Journal of Nuclear Medicine shows that 18F-fludeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography (CT) imaging offers significant prognostic stratification information at initial staging for patients with locally advanced breast cancer. When compared to conventional imaging, 18F-FDG PET/CT more accurately showed lesions in the chest, abdomen and bones in a single session, changing management for more than 50 percent of the patients in the study.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now